API site WHO GMP risk during internal gap assessment – avoiding repeat WHO observations



Published on 28/01/2026

Navigating WHO GMP Risks in API Sites During Internal Gap Assessments

Internal gap assessments at API sites are essential yet complex processes that critically determine compliance with WHO GMP standards. Many facilities encounter recurrent observations during audits and inspections, which can jeopardize their regulatory standing and market access. Understanding how to effectively conduct these assessments can help mitigate risks, avoid repeat observations, and ensure high-quality production processes.

This playbook aims to equip quality and manufacturing professionals with actionable insights to navigate the risks associated with WHO GMP compliance during internal gap assessments. You’ll learn how to identify symptoms of potential non-compliance, investigate root causes, implement effective CAPA strategies, and maintain inspection readiness. This guide is designed for professionals in Manufacturing, Quality Control (QC), Quality Assurance (QA), Engineering, and Regulatory Affairs (RA), who seek tangible solutions to enhance their compliance frameworks.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms that indicate potential

non-compliance with WHO GMP is the first step in mitigating risks. Common signals include:

  • Unexpected Variability: Frequent deviations in batch consistency or quality.
  • Documentation Gaps: Incomplete or inaccurate batch records, log entries, or deviation reports.
  • Equipment Malfunction: Unscheduled downtimes or performance degradation of critical machinery.
  • Employee Feedback: Observations from operators regarding procedural inconsistencies or safety lapses.
  • Audit Findings: Previous audit reports revealing recurring issues or areas needing improvement.

Recognizing these signals allows for timely intervention, preventing minor discrepancies from escalating into major compliance issues. Monitoring should be a continuous process, involving both routine checks and employee training to ensure awareness of compliance standards.

Likely Causes

Understanding the underlying causes of compliance issues can facilitate effective interventions. Potential causes can be categorized into six key domains:

Category Likely Causes
Materials Substandard raw materials, improper storage conditions, outdated suppliers.
Method Outdated or improperly validated SOPs, incomplete training of personnel.
Machine Equipment calibration failures, lack of maintenance, outdated technology.
Man Training gaps, low awareness of compliance issues, high turnover rates.
Measurement Deficient testing methodologies, inaccurate measuring instruments, lack of preventive measures.
Environment Contamination risks, unstable temperature/humidity, inadequate cleaning protocols.
Pharma Tip:  Documentation not aligned to WHO during API sourcing – CAPA aligned to WHO standards

Conducting a thorough investigation into these areas will assist in pinpointing specific compliance failures, setting the stage for a targeted action plan.

Immediate Containment Actions (first 60 minutes)

In the event of a compliance breach, performing immediate containment actions is crucial to prevent further impact. The following steps should be taken within the first hour:

  1. Alert the Relevant Teams: Notify manufacturing, quality assurance, and regulatory affairs teams of the issue.
  2. Cease Production (if necessary): If a significant compliance breach is identified, halt production processes immediately to mitigate risk.
  3. Document the Incident: Create a preliminary documentation record detailing the initial observations and responses.
  4. Initiate Monitoring: Implement heightened monitoring of affected batches and areas of concern to gather data.
  5. Fetch Immediate Information: Collect any data that could clarify the situation, including logs, testing results, and personnel accounts.

Acting swiftly not only protects the product quality but also provides a clear paper trail essential for subsequent investigations and compliance demonstration.

Investigation Workflow

Once a non-compliance issue has been identified, a structured investigation is paramount. Follow these steps:

  1. Gather Evidence: Collect all relevant data, including batch records, test results, SOPs, and environmental monitoring reports.
  2. Interviews: Conduct interviews with key personnel frequently involved in or impacted by the issue, documenting their insights.
  3. Timeline Analysis: Create a chronological timeline of events leading up to the issue, helping identify potential triggers.
  4. Data Analysis: Evaluate data for trends or anomalies that could indicate systemic problems (e.g., SPC charts, run charts).
  5. Preliminary Findings: Develop initial hypotheses to test during the follow-up investigation phase.

Documenting the entire investigation workflow is crucial for regulatory compliance. Make sure to keep detailed records that can showcase the evidence collected and actions taken.

Root Cause Tools

After gathering sufficient data, it’s essential to apply the right root cause analysis tools to identify the underlying problem. Here are three methodologies:

5-Why Analysis

This straightforward technique involves asking “Why?” up to five times to drill down to the core of an issue. It’s particularly useful for less complex problems.

Fishbone Diagram

Also known as the Ishikawa diagram, this tool visually displays potential causes grouped by categories (e.g., Methods, Machines, People). It’s beneficial for multi-faceted issues requiring group brainstorming.

Fault Tree Analysis

This tool employs logic trees to understand the pathways that led to a particular failure event. It’s suited for complex, technical situations where precise cause identification is necessary.

Pharma Tip:  Inadequate WHO GMP training during API sourcing – evidence pack for WHO audits

Select the appropriate tool based on the complexity of the issue and the data at hand. It may also be helpful to involve cross-functional teams in this stage to ensure diverse perspectives are considered.

CAPA Strategy

Once root causes have been identified, it’s critical to formulate an effective CAPA (Corrective and Preventive Action) strategy:

  • Correction Actions: Immediately address the specific issue found to bring procedures back into compliance.
  • Corrective Actions: Implement changes that address the root causes identified, such as revising SOPs, enhancing training, or upgrading equipment.
  • Preventive Actions: Establish ongoing monitoring and control measures to ensure the issue does not reoccur, including regular reviews of processes and equipment performance.

Document all CAPA strategies and ensure they are communicated across relevant teams to facilitate effective implementation.

Control Strategy & Monitoring

To ensure sustained compliance with WHO GMP, develop a robust control strategy that includes:

Related Reads

  • Statistical Process Control (SPC): Implement SPC techniques to analyze process variation, allowing for proactive correction before deviations occur.
  • Regular Sampling: Conduct routine sampling of raw materials and products at critical stages to confirm quality standards.
  • Alert Systems and Alarms: Set up alarms for critical parameters (temperature, humidity, etc.), providing alerts for immediate action.
  • Verification Processes: Establish procedures for periodic verification of processes through internal or external audits.

Regularly review these control strategies to adapt to new challenges and ensure ongoing compliance with WHO guidelines.

Validation / Re-qualification / Change Control Impact

Compliance issues often necessitate a reevaluation of existing validation and change control protocols. Necessary steps include:

  • Document Review: Assess any existing validation protocols for relevance in light of new findings.
  • Re-qualification of Equipment: If equipment failures contributed to non-compliance, ensure proper re-qualification and validation of associated processes.
  • Change Control Procedures: Any CAPA measures implemented should initiate a formal change control process to ensure all alterations are appropriately documented and assessed for impact.

Integrating these practices helps ensure that past deficiencies do not cascade into future compliance issues, streamlining the pathway to audit readiness.

Inspection Readiness: What Evidence to Show

During regulatory inspections, preparedness is key. Key elements of inspection readiness include:

  • Records of Investigations: Maintain comprehensive records of investigations, including evidence collected, analysis performed, and decisions taken.
  • Documentation of CAPA: Clearly document all CAPA actions and maintain evidence of their implementation and effectiveness.
  • Training Records: Ensure that training records for all personnel involved in compliance-related processes are current and accessible.
  • Batch Documentation: Ensure that batch records and related documentation are complete and reflect current operational procedures.
  • Deviation Logs: Document all deviations and the corrective measures taken, demonstrating a proactive stance on compliance.
Pharma Tip:  Documentation not aligned to WHO during remediation planning – gap remediation roadmap

Being prepared with robust documentation fosters confidence during inspections and showcases the organization’s commitment to quality standards.

FAQs

What are the common signs of non-compliance during audits?

Common signs include unexpected variability in product quality, incomplete documentation, and equipment malfunction.

How can I effectively perform a root cause analysis?

Utilize tools like the 5-Why analysis, Fishbone diagram, or Fault Tree analysis depending on the complexity of the issue.

What immediate actions should I take upon identifying a compliance breach?

Alert relevant teams, cease production if necessary, document the incident, and implement increased monitoring.

How often should I review my control strategy?

Regular reviews should be conducted at least quarterly or following any significant changes in processes or products.

What is the role of CAPA in compliance?

CAPA involves identifying corrective actions to address existing issues and preventive actions to avoid future incidents.

What should I include in my validation or re-qualification processes?

Document reviews, equipment checks, and adjustments to processes in response to findings should be included in validation procedures.

How do I ensure inspection readiness?

Maintain thorough documentation, training records, and evidence of compliance with all established procedures.

Where can I learn more about WHO GMP compliance requirements?

Refer to the official WHO guidelines and standards for comprehensive information on requirement specifics.

What is the significance of SPC in manufacturing?

SPC allows for monitoring of process variability, enabling proactive identification of potential quality issues before they escalate.

What records are essential for audit preparation?

Essential records include batch documentation, investigation logs, CAPA documentation, and training records.

Who should be involved in the investigation of compliance issues?

Key personnel from manufacturing, quality assurance, and regulatory affairs should participate in investigations for comprehensive insights.

What are the immediate containment actions after a compliance breach?

Immediate actions include alerting teams, halting affected production, documenting the incident, and initiating monitoring.